General MedicationsORALGeneric
RIBAVIRIN
RIBAVIRIN
Standard Dose
40MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary
Approval overview RIBAVIRIN is listed in Drugs@FDA under application 077611 (ANDA).
Marketing status: None (Tentative Approval) Active ingredient RIBAVIRIN Form and strength SOLUTION; ORAL - 40MG/ML Sponsor TEVA PHARMS Submission history Latest submission status date: 2011-03-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview RIBAVIRIN is listed in Drugs@FDA under application 077611 (ANDA). Marketing status: None (Tentative Approval) Active ingredient RIBAVIRIN Form and strength SOLUTION; ORAL - 40MG/ML Sponsor TEVA PHARMS Submission history Latest submission status date: 2011-03-28 00:00:00. Submission type: ORIG.
Monitoring
- • Review priority: STANDARD
- • Marketing status: None (Tentative Approval)
Interaction Notes
- No interaction notes stored yet.